Microbial Metabolite from Berries May Help Address Bowel Disease

Microbial Metabolite from Berries May Help Address Bowel Disease

  • Research Stash
  • News
  • 2.1K

A group of Indian researchers has found that a substance formed during the process of metabolism of berries and pomegranates in the human gut may help mitigate inflammatory bowel disease (IBD) that afflicts millions of people globally.

Picture of Praveen Vemula (left) and Sandeep Chandrashekharappa (right) at inStem, Bengaluru
Picture of Praveen Vemula (left) and Sandeep Chandrashekharappa (right) at inStem, Bengaluru

IBD is usually marked by chronic intestinal inflammation and does not have any effective remedy at present. The metabolite formed during the breaking down of berries and pomegranates in the gut with the help of gut bacteria boosts certain proteins critical for keeping the gut lining strong. The metabolite helps the cells in the gut lining to remain glued to each and not allow toxins to penetrate. The researchers have also found a synthetic version of the metabolite to be effective in laboratory studies.

Illustration showing tightening of gut barrier cells and reduced inflammation due to gut metabolite, by Praveen Kumar Vemula, inStem, India.
Illustration showing tightening of gut barrier cells and reduced inflammation due to a gut metabolite, by Praveen Kumar Vemula, inStem, India.

The barrier in the gut lining is made up of a single-cell layer that provides protection against antigens and toxins present in the gut. The cells remain together with the help of certain proteins like claudins and zona occludin-1. Loss of these cell-cell junction proteins causes IBD and makes the protective layer permeable.

The microbial metabolite called Urolithin A (UroA)) derived from berries and pomegranates has been found to boost cell junction proteins. The metabolite is derived from polyphenolics of berries. Metabolites are intermediary products produced during the process of metabolism.

The researchers have also found the mechanism by which the microbial metabolite and its analog reduce inflammation and restore gut barrier integrity. The results of the study, done by researchers at the Bangalore-based Institute for Stem Cell Biology and Regenerative Medicine (InStem) and the University of Louisville, have been published in journal Nature Communications on Thursday. In this paper, Praveen Kumar Vemula and Venkatakrishna Rao Jala are senior authors, with Rajbir Singh.

“Restoring the gut barrier and reducing the inflammation using a small-molecule will provide a better therapeutic output in the treatment of IBD,” said Dr. Vemula of InStem.

“The general belief thus far in the field is that Urolithins have a beneficial effect only through their anti-inflammatory property. We have discovered that their major mode of function is repairing the gut barrier dysfunction,” added Rajbir Singh, a postdoctoral fellow at the University of Louisville.

The new agent has been found to be both therapeutic and preventive effect in initial studies in mice. Vemula and Jala said they plan to set up a start-up based on this technology and aim to develop the molecule as a drug.

The research was supported by the Department of Biotechnology, India and National Institute of Health, USA.  (India Science Wire)

By Dinesh C Sharma

Journal Article

Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook.

The microbial metabolite called Urolithin A (UroA)) derived from berries and pomegranates has been found to boost cell junction proteins. The metabolite is derived from polyphenolics of berries. Metabolites are intermediary products produced during the process of metabolism.

The researchers have also found the mechanism by which the microbial metabolite and its analog reduce inflammation and restore gut barrier integrity. The results of the study, done by researchers at the Bangalore-based Institute for Stem Cell Biology and Regenerative Medicine (InStem) and the University of Louisville, have been published in journal Nature Communications on Thursday. In this paper, Praveen Kumar Vemula and Venkatakrishna Rao Jala are senior authors, with Rajbir Singh.

“Restoring the gut barrier and reducing the inflammation using a small-molecule will provide a better therapeutic output in the treatment of IBD,” said Dr. Vemula of InStem.

“The general belief thus far in the field is that Urolithins have a beneficial effect only through their anti-inflammatory property. We have discovered that their major mode of function is repairing the gut barrier dysfunction,” added Rajbir Singh, a postdoctoral fellow at the University of Louisville.

The new agent has been found to be both therapeutic and preventive effect in initial studies in mice. Vemula and Jala said they plan to set up a start-up based on this technology and aim to develop the molecule as a drug.

The research was supported by the Department of Biotechnology, India and National Institute of Health, USA.  (India Science Wire)

By Dinesh C Sharma

Journal Article

Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook.

" }

Get Ready for Taiwan’s Biggest Smart City Summit and Expo

We’re excited to be one of the media partner for the upcoming SMART CITY SUMMIT & EXPO which is going to be held in Taipei, Taiwan from March 27th to March 30th, 2018.

  • News
  • 3.6K
Read more

Science Films Can Help Promote Scientific Temperament

Over 200 films makers along with a large contingent of scientists, students and film critics from across the country have gathered here for the eighth edition of the National Science Film Festival of India (NSFFI) which began today at the P.D Hall of Gauhati University.

  • News
  • 1.4K
Read more

Scientists A Step Closer To Potential Vaccine against Leptospirosis

Leptospirosis - caused by pathogenic bacteria, Leptospira - led to over one million infections globally in 2015. Availability of an appropriate vaccine could have prevented most of them.

  • News
  • 2.5K
Read more

Internet is huge! Help us find great content

Newsletter

Never miss a thing! Sign up for our newsletter to stay updated.

About

Research Stash is a curated collection of tools and News for S.T.E.M researchers

Have any questions or want to partner with us? Reach us at hello@researchstash.com

Navigation

Submit